Related Experiment Video
Updated: Nov 3, 2025

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
The Chemistry Behind ADCs
Vesela Kostova1, Patrice Désos1, Jérôme-Benoît Starck1
1Drug Design Small Molecules Unit, Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy-sur-Seine, France.
Antibody-drug conjugates (ADCs) offer targeted cancer therapy by combining antibodies with cytotoxic drugs. This review focuses on the chemical methods for assembling ADCs and controlling drug release for improved cancer treatment.
Area of Science:
- Medicinal Chemistry
- Oncology
- Drug Development
Background:
- Antibody-drug conjugates (ADCs) are an effective cancer therapy, leveraging targeted cell recognition and potent cytotoxic payloads.
- Numerous ADCs are approved or in clinical development, highlighting their therapeutic significance.
Purpose of the Study:
- To review the chemistry of ADCs from a medicinal chemistry perspective.
- To focus on chemical methods for ADC assembly and controlled drug payload release.
Main Methods:
- Review of chemical methodologies for ADC construction.
- Analysis of linker chemistry and its impact on drug release.
Main Results:
- Discussion of strategies for selecting antibodies and drug payloads based on disease pharmacology.
- Emphasis on the choice of chemical linkers for efficient ADC assembly.
Conclusions:
- The chemical assembly and controlled release of drug payloads are critical for ADC efficacy.
- Medicinal chemistry plays a vital role in advancing ADC-based cancer therapeutics.
More Related Videos
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
08:47Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
Related Concept Videos
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Phase II Conjugation Reactions: Overview
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Affinity and Avidity
Drug Distribution: Plasma Protein Binding